Editorial Diagnostics and therapeutics: the CRISPR story continues The Lancet Microbe +++ +...

Safety, recovery, and pharmacodynamics of CRISPR–Cas therapeutic SNIPR001: a phase 1, randomised, double-blind, first-in-human, dose-escalation study Anders Østergaard Petersen, PhDa ∙ Birgitte Damholt, PhDa ∙ Mette Grove, PhDa ∙ Jonas Hink, PhDa ∙ Tamara Marotte-Hurbon, MSca ∙ Johan Söderqvist, MSca ∙ et al. https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(25)00185-5/fulltext?dgcid=hubspot_update_feature_updatealerts_lanmic&utm_campaign=update-lanmic&utm_medium=email&_hsenc=p2ANqtz-9BtKlzOmT-8aVyPJkIoM-dxwbV6Gh0SSs8sVZt38ILMIvSB_ULBehzdASlcts_7p-Q9HrHEXBu-LITmHpjxrPYYBca4Q&_hsmi=414946141&utm_content=414664356&utm_source=hs_email Safety, colonisation kinetics, transmissibility, and immune correlates of protection in healthy adults inoculated with Bordetella pertussis in England: a single-centre, open-label, phase 1, controlled human infection study Hans de Graaf, PhDa,b,c,d,∗ ∙ Diane F Gbesemete, PhDa,b,e,∗ ∙ Alison R Hill, PhDa,b,e,∗ ∙ Janeri Fröberg, PhDc,d ∙ Muktar M Ibrahim, PhDe ∙ Adam P Dale, PhDa,b,e ∙ et al. https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(25)00241-1/fulltext?dgcid=hubspot_update_feature_updatealerts_lanmic&utm_campaign=update-lanmic&utm_medium=email&_hsenc=p2ANqtz-99dyMyxjhTJfb5i_TU7ROzf9mVTqtKS9kNSSOUKyJT4ujuPoLPdKPYFwAUwLm2lOt28O6tm22QTEuCTarKosooMV77zA&_hsmi=414946141&utm_content=414664356&utm_source=hs_email Lineage dynamics of invasive Escherichia coli isolates in the Netherlands from 1975 to 2021: a retrospective longitudinal genomic analysis Ann E Snaith, PhDa,∗ ∙ Boas van der Putten, PhDb,c,∗ ∙ Wendy Bril-Keijzers, BScb ∙ Rebecca J Hall, PhDa ∙ Steven J Dunn, PhDa ∙ Prof Willem van Schaik, PhDa ∙ et al. https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(25)00228-9/fulltext?dgcid=hubspot_update_feature_updatealerts_lanmic&utm_campaign=update-lanmic&utm_medium=email&_hsenc=p2ANqtz-91tusPdEbxZGWXU6-SuIgwv5nq3muzvHfF0iH6yPaoJyKgYSC1k5tEbkjl5RdM7E8JkFMcLSsGv2P2audbbeRrHRH-nA&_hsmi=414946141&utm_content=414664356&utm_source=hs_email Editorial Diagnostics and therapeutics: the CRISPR story continues The Lancet Microbe https://www.thelancet.com/journals/lanmic/issue/vol7no4/PIIS2666-5247(26)X2003-1